89Zr-Onartuzumab PET imaging of c-MET receptor dynamics. - Wikidata - awgldk - TriplyDB

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

http://www.wikidata.org/entity/Q33841490

about

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

http://www.wikidata.org/entity/Q33841490

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

@ast

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

@en

type

label

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

@ast

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

@en

prefLabel

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

@ast

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

@en

P1433

Q33841490-73323A48-FD09-45D1-AE89-591C375E98BF

P1476

Q33841490-16F06BC2-31E2-4ECB-8465-A5B21B87FEE2

P2093

Q33841490-073651C6-8DA7-4466-A66B-21E9769C4B0A

Q33841490-33701496-0DA4-4389-A8CB-B2C545BB8581

Q33841490-8D8CCD01-9730-4B98-AC67-45941594F4AC

Q33841490-9B14DA41-B28C-432F-BC7D-F6F4477E383E

Q33841490-E4861199-AAA6-4F4D-923A-D0758D4D50CE

P2860

Q33841490-0D34D863-F91C-421A-A0EC-E9A8326352B8

Q33841490-0EDBB8EE-0535-443B-B7FB-62E919F25079

Q33841490-1404360C-7FE6-441F-AA0C-B379D8F0A0EE

Q33841490-1D6DFF16-2674-4B25-A823-9CE9B13BB832

Q33841490-2246A004-8947-4942-91F7-3A4B29197520

Q33841490-2B5FCD76-D843-47F0-BA6B-4129E09C9E6B

Q33841490-2CF25566-BC5E-49D6-89CC-63ECF67D041B

Q33841490-2F1A6818-1A7A-46AE-AE3F-9FC862C3630E

Q33841490-4567076C-6C63-42B2-8659-D8CDF788F998

Q33841490-48154D11-A602-42D3-9BAF-9CF839690C82

P2888

Q33841490-80D43915-31CC-48A1-93A8-3DB03E982842

P304

Q33841490-29275C5F-3A7B-4F8D-AE18-DD7C95E006E0

P31

Q33841490-E58A9161-4DE4-4618-A36B-CB11F056017F

P356

Q33841490-E57CB558-C428-4809-96AA-DE54A3AB54B3

P433

Q33841490-81CAC782-7D68-4C62-AA9F-3622164C213F

P478

Q33841490-8FEBE0FF-3CC7-4F28-B05E-1CAD7D5CE537

P50

Q33841490-06FE8F66-8FC7-439C-A88C-6F3EA5A67C98

P577

Q33841490-115685DA-0135-4343-A4B5-E5420CE4A968

P698

Q33841490-71FD92A7-79E0-492D-BD22-70BDA03F781C

P932

Q33841490-6F2AC25A-8B9D-4EC3-8E4F-D76861D0973A

P356

S00259-017-3672-X

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics

@en

P2093

Anton G T Terwisscha van Scheltinga

http://www.w3.org/2001/XMLSchema#string

Arjan Kol

http://www.w3.org/2001/XMLSchema#string

Danique Giesen

http://www.w3.org/2001/XMLSchema#string

Marjolijn N Lub-de Hooge

http://www.w3.org/2001/XMLSchema#string

Martin Pool

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting the hepatocyte growth factor-cMET axis in cancer therapy

Thirty years of research on met receptor to move a biomarker from bench to bedside

Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.

Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody ⁸⁹Zr-RG7116

P2888

s00259-017-3672-x

P304

1328-1336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-017-3672-X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Elisabeth de Vries

P577

2017-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28315949

http://www.w3.org/2001/XMLSchema#string

P932

5486818

http://www.w3.org/2001/XMLSchema#string